NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.

Carre?n T, Ruder AM, Schulte PA, Hayes RB, Rothman N, Waters M, Grant DJ, Boissy R, Bell DA, Kadlubar FF, Hemstreet GP, Yin S, LeMasters GK. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer. 2006 Jan 01; 118(1):161-8.

View in: PubMed

authors with profiles

Delores Grant

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support